What the published evidence says about the most-requested hair-fall actives, which format each one suits, and how to build a range that sells on proof rather than promises.
Disclosure: This article is published by ORIZI Group and may refer to our own manufacturing experience, services and capabilities. External factual claims are supported by cited sources.
Key takeaways
- Malaysian search demand is shifting to growth oils and serums: “hair growth oil” is up 125% year on year and “rosemary oil for hair growth” up 84%.
- Caffeine has more human data than any other cosmetic hair-fall active and works in both shampoos and leave-on tonics.
- Rosemary oil has strong consumer recognition and one randomised trial; results appeared at six months, not three.
- Branded complexes such as Redensyl have small, often combination-product studies and suit premium positioning.
- Biotin, castor oil and ginger sell on familiarity but have weak topical evidence; use them as supporting ingredients.
What this guide covers
This guide covers cosmetic shampoos, tonics, serums and scalp oils sold for hair fall; registered medicines appear only as trial benchmarks. Redensyl, Capixyl and Procapil are trade names of their respective ingredient suppliers.
Androgenetic alopecia is the common inherited pattern of hair thinning, which a 2020 clinical study describes as affecting approximately 50% of men and women (Katoulis 2020). Anagen is the growing phase of the hair cycle and telogen the resting phase before a hair sheds, so many trials report an anagen-to-telogen ratio. A branded active complex is a supplier’s blend of actives sold under a trade name with its own supporting studies.
What are Malaysian consumers searching for?
| Keyword (Malaysia) | Avg monthly searches | Year on year |
|---|---|---|
| biotin oil | 8,100 | −19% |
| hair growth serum | 1,600 | +23% |
| rosemary oil | 1,600 | −33% |
| shampoo for hair fall | 720 | 0% |
| hair growth oil | 590 | +125% |
| rosemary oil for hair growth | 480 | +84% |
| castor oil for hair growth | 210 | +133% |
| minoxidil shampoo | 210 | +52% |
Source: Google Keyword Planner, Malaysia, average monthly searches July 2025 to June 2026, exported and analysed by ORIZI Group in October 2026.
Which ingredients are used in anti-hair-fall products?
The table summarises the strongest published evidence we found for each common active. “Weak” does not mean an ingredient is useless in a formula; it means it should not carry the product’s proof on its own.
| Active (INCI) | Key published evidence | Our read |
|---|---|---|
| Caffeine | Open-label randomised trial, 210 men, 6 months: a 0.2% caffeine liquid was non-inferior to 5% minoxidil on anagen improvement (10.6% vs 11.7%) (Dhurat 2017). Review of 9 trials, 684 people: all favourable, but evidence quality mostly low or very low (Szendzielorz & Spiewak 2025). | Moderate; most human data |
| Rosemary oil (Rosmarinus Officinalis Leaf Oil) | Randomised trial, 100 people with androgenetic alopecia: hair count rose in both the rosemary oil and 2% minoxidil groups at 6 months (not at 3), with no difference between groups and less scalp itch with rosemary (Panahi 2015). | Limited; one trial |
| Redensyl (branded complex) | Single-blind, vehicle-controlled study, 44 patients, 24 weeks, lotion combining Redensyl and Sepicontrol A5: active-group anagen-to-telogen ratio rose from 2.25 to 6.02 (Katoulis 2020). | Limited; small, combination product |
| Acetyl Tetrapeptide-3 with red clover (biochanin A) | Triple-blind randomised trial, 32 adults, 24 weeks: a blend with ginseng extract matched 3% minoxidil on terminal hair count (+8.3% vs +8.7%, no significant difference) (Lueangarun 2020). | Limited; small trial |
| Procapil (biotinoyl tripeptide-1 complex) | Studied mainly alongside in-clinic platelet-rich plasma (PRP) treatment, which makes its own contribution hard to isolate (Tr P 2023). | Weak as a standalone |
| Peppermint oil (Mentha Piperita Oil) | Mouse study: 3% oil over 4 weeks increased follicle number and depth (Oh 2014). | Preclinical only |
| Biotin | Benefit reported only in people with deficiency or specific conditions; insufficient evidence in healthy people (Patel 2017). | Weak |
| Castor oil (Ricinus Communis Seed Oil) | Systematic review: weaker evidence for hair lustre, no strong evidence for growth (Phong 2022). | Weak |
| Ginger (Zingiber Officinale Root Extract) | Long traditional use in Asian hair and scalp care, valued for its warming feel; topical clinical data on hair growth are limited, so it suits a supporting scalp-care and story role. | Supporting |
Caffeine also has the clearest mechanism story. In cultured follicles from men with androgenetic alopecia, caffeine counteracted testosterone-driven growth suppression (Fischer 2007), and caffeine applied in a shampoo for two minutes reached the skin through the hair follicles (Otberg 2007). That is why caffeine is one of the few actives that makes sense in a rinse-off product.
How strong is the evidence overall?
The evidence for cosmetic hair-fall actives is encouraging but small. A 2025 review of 13 investigator-blinded controlled trials of non-prescription products, covering caffeine, rosemary oil, saw palmetto, pumpkin seed oil and others, found improvements in at least one measure such as hair density or diameter, with few adverse events, and called for larger, longer trials (Gupta 2025). Most studies are small, many test a blend rather than one ingredient, and endpoints differ, so results cannot be ranked against each other.
Which product format suits which active?
| Format | Contact time | Suits | Watch-out |
|---|---|---|---|
| Shampoo | Minutes, rinsed off | Caffeine; rosemary or ginger for scent and story | Expensive leave-on complexes are largely washed away |
| Tonic or spray | Leave-on, light | Caffeine, peptides, scalp-comfort actives | Must dry fast and not grease hair or headwear |
| Serum (dropper) | Leave-on | Branded complexes and peptides | Price point must carry the active cost |
| Scalp oil | Leave-on, anhydrous | Rosemary, peppermint, castor and local oils | Essential-oil levels are capped by the safety assessment |
Leave-on formats give actives the longest contact, so the better-evidenced ingredients usually go into the tonic or serum. Shampoo development is covered on our OEM shampoo manufacturing page.
How do you build an anti-hair-fall range step by step?
- Choose the consumer. Men and postpartum mothers recur as explicit segments in Malaysian search suggestions we collected in October 2026 (see men’s grooming opportunities in Malaysia).
- Pick one evidence-led hero. Caffeine for mass price points; a branded complex for premium serums, where delivery matters as explained in encapsulated peptides are a process decision.
- Add one recognition ingredient. Rosemary, ginseng or ginger gives the story shoppers already search for.
- Match the format to contact time, using the table above.
- Fix claim wording and substantiation before artwork, including any in-use or consumer test that a percentage on pack would need.
- Test the final pack for stability, compatibility and preservation through our product testing service.
ORIZI perspective: what sells is not always what is proven
Our October 2026 market scan of 56 hair-loss and scalp-care products, drawn from Lazada and Watsons Malaysia, other ASEAN marketplaces and Amazon US, found the same hero ingredients again and again: ginger, rosemary, ginseng and fleeceflower, caffeine (often with saw palmetto in men’s lines), local oils such as kemiri, castor and olive, and vitamin-and-panthenol tonics. Branded complexes such as Redensyl, Capixyl and Procapil rarely appeared in mass Malaysian listings. The formats that recurred among top sellers were 500 ml shampoos, 100 ml tonics with a spray or nozzle, 50 to 120 ml oils with a dropper or roller-comb, and shampoo-plus-tonic duos.
Set against the evidence table, the scan shows a gap: the most familiar local heroes are the least proven. Our recommendation is to keep the heritage ingredient for recognition and let caffeine or a branded complex carry the proof. Our active ingredient library already includes AnaGain (a pea sprout extract from Mibelle Biochemistry used in our shampoo and scalp tonic concepts) and Apiscalp (a celery-seed active from Croda Beauty for scalp comfort); their efficacy data comes from the suppliers rather than independent trials. Dr Orizi (M) Sdn. Bhd. manufactures these formats under NPRA cosmetic GMP and JAKIM Halal certification, and on a JAKIM-certified line each active also needs acceptable halal status. Eligible ready formulas can pilot from 50 units under Ready2Brand. The limit of this view: a market scan shows what sells, not what works.
Risks, limitations and common mistakes
- Promising results in weeks. The trials above ran 24 weeks or six months, and rosemary oil showed no change at three months.
- Copying a study percentage into a different base. Many trials do not report the active concentration, as the 2025 caffeine review noted, and the vehicle changes delivery.
- Overloading essential oils. Rosemary and peppermint oils are fragrance materials; dose them within the safety assessment and IFRA limits.
- Letting a weak ingredient carry the proof. Biotin, castor and ginger are fine supporting ingredients but poor headline evidence.
- Skipping halal checks on actives. Peptides, biotin and botanical extracts each need acceptable source documentation; see our halal ingredients guide.
Registration category note
In Malaysia and ASEAN, anti-hair-fall shampoos, tonics, serums and scalp oils are cosmetics notified to NPRA. NPRA’s claims guideline accepts wording such as “anti-hair loss/hair fall” (due to physical factors such as breakage), “helps to strengthen/nourish hair root” and “promote healthy hair”, while “stimulate/promote hair growth” and claims about hereditary or hormonal hair loss belong outside the cosmetic category (NPRA Annex I Part 8). Minoxidil is listed in Annex II, the substances that must not be used in cosmetics (NPRA Annex II), so a minoxidil product follows the registered-medicine (MAL) route. In the US, claims to restore hair growth make a product a drug (FDA). Line-by-line claim wording is covered in why a scalp serum brief often becomes two products.
FAQ
Does rosemary oil really help with hair growth?
Rosemary oil has one notable randomised trial: in 100 people with androgenetic alopecia, hair count rose after six months in both the rosemary oil group and the 2% minoxidil group, with no significant difference between them. It is promising but rests on a single study, so it is most useful paired with a better-evidenced active such as caffeine.
Is caffeine shampoo effective for hair fall?
Caffeine has the most human data among cosmetic hair-fall actives. It reaches the follicles even from a two-minute shampoo application, and a 210-man trial found a 0.2% caffeine liquid non-inferior to 5% minoxidil. A leave-on tonic adds contact time.
Can I private label a hair growth serum in Malaysia?
Yes, as a cosmetic scalp serum notified to NPRA, with label claims kept to accepted wording such as reducing hair fall from breakage and strengthening the hair root. ORIZI develops scalp serums, tonics and oils from ready or custom formulas; see our hair serum and oil manufacturing page.
Can a cosmetic hair tonic contain minoxidil?
No. Minoxidil and its salts are on the ASEAN Annex II list of substances that must not be used in cosmetic products, so a minoxidil product must be registered as a medicine with NPRA instead.
How long before an anti-hair-fall product shows results?
Most clinical studies measure results at 24 weeks or six months, and the rosemary oil trial found no change at three months. Brands should set customer expectations, and any in-use test, around a three- to six-month routine.
Sources & references
- Dhurat R et al., Skin Pharmacol Physiol 2017 — caffeine 0.2% vs minoxidil 5%
- Szendzielorz E, Spiewak R, Healthcare 2025 — systematic review of topical caffeine
- Fischer TW et al., Int J Dermatol 2007 — caffeine in cultured follicles
- Otberg N et al., Skin Pharmacol Physiol 2007 — follicular penetration from shampoo
- Panahi Y et al., Skinmed 2015 — rosemary oil vs minoxidil 2%
- Katoulis AC et al., Dermatol Ther 2020 — Redensyl blend vs vehicle
- Lueangarun S, Panchaprateep R, J Clin Aesthet Dermatol 2020 — acetyl tetrapeptide-3 blend vs minoxidil 3%
- Tr P et al., Cureus 2023 — Procapil with PRP
- Gupta AK et al., Skin Appendage Disord 2025 — review of non-prescription products
- Oh JY et al., Toxicol Res 2014 — peppermint oil in mice
- Patel DP et al., Skin Appendage Disord 2017 — biotin review
- Phong C et al., J Drugs Dermatol 2022 — coconut, castor and argan oil review
- NPRA Annex I Part 8 — Guideline for Cosmetic Claims — acceptable hair claims
- NPRA Annex II (June 2026 release) — minoxidil prohibited in cosmetics
- US FDA — Is It a Cosmetic, a Drug, or Both? — hair-growth claims as drug claims
Update history: October 2026 — first published.
Planning an anti-hair-fall range? Start with our hair serum and scalp oil manufacturing options, or send a short project brief with your target consumer, format and price point.
